Literature DB >> 9584624

G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways.

L A Selbie1, S J Hill.   

Abstract

Signalling via the large family of G protein-coupled receptors (GPCRs) can lead to many cellular responses, ranging from regulation of intracellular levels of cAMP to stimulation of gene transcription. Members of this receptor family have been grouped into different categories dependent on the particular G protein subtypes that they predominantly interact with. Thus, receptors that couple to GS proteins will stimulate adenylate cyclase in many cells, while Gq/11-coupled receptors can mobilize intracellular Ca2+ via activation of phospholipase C. There is accumulating evidence, however, that activation of one particular signalling pathway by a GPCR can amplify intracellular signalling within a parallel but separate pathway. In this article Lisa Selbie and Stephen Hill review some of the evidence for these synergistic interactions and suggest that they may have an important role in finetuning signals from multiple receptor signalling pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9584624     DOI: 10.1016/s0165-6147(97)01166-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  87 in total

1.  Thymocyte emigration is mediated by active movement away from stroma-derived factors.

Authors:  Mark C Poznansky; Ivona T Olszak; Richard H Evans; Zhengyu Wang; Russell B Foxall; Douglas P Olson; Kathryn Weibrecht; Andrew D Luster; David T Scadden
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 3.  Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.

Authors:  Steven J Charlton; Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 4.  Purinergic regulation of epithelial transport.

Authors:  R Elaine Bucheimer; Joel Linden
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

Review 5.  Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.

Authors:  C B Brink; B H Harvey; J Bodenstein; D P Venter; D W Oliver
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

6.  Molecular assays for characterization of alternatively spliced isoforms of the u opioid receptor (MOR).

Authors:  Pavel Gris; Philip Cheng; John Pierson; William Maixner; Luda Diatchenko
Journal:  Methods Mol Biol       Date:  2010

Review 7.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

8.  Postsynaptic GABAB receptor signalling enhances LTD in mouse cerebellar Purkinje cells.

Authors:  Yuji Kamikubo; Toshihide Tabata; Sho Kakizawa; Daisuke Kawakami; Masahiko Watanabe; Akihiko Ogura; Masamitsu Iino; Masanobu Kano
Journal:  J Physiol       Date:  2007-10-18       Impact factor: 5.182

9.  Emergent decision-making in biological signal transduction networks.

Authors:  Tomás Helikar; John Konvalina; Jack Heidel; Jim A Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

10.  A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes.

Authors:  Valérie Capra; Maria Rosa Accomazzo; Fabrizio Gardoni; Silvia Barbieri; G Enrico Rovati
Journal:  J Lipid Res       Date:  2009-11-15       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.